In situ islet cytokine gene expression during development of type I diabetes in the non-obese diabetic mouse
- 31 March 1994
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 39 (3) , 283-288
- https://doi.org/10.1016/0165-2478(94)90170-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- T-cell autoimmunity in type 1 diabetes mellitusCurrent Opinion in Immunology, 1993
- In situ islet T cell receptor variable region gene usage in the nonobese diabetic mouseImmunology Letters, 1992
- Quantitative and Functional Analyses of Spleen and in Situ Islet Immune Cells Before and After Diabetes Onset in the Nod MouseAutoimmunity, 1992
- Type-I Diabetes: A Chronic Autoimmune Disease of Human, Mouse, and RatAnnual Review of Immunology, 1990
- Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice.Journal of Clinical Investigation, 1989
- T Cell Receptors in Murine Autoimmune DiseasesAnnual Review of Immunology, 1989
- Differential secretion of tumor necrosis factor-α and granulocyte/macrophage colony-stimulating factors but not interferon-γ from CD4 compared to CD8 human T cell clonesEuropean Journal of Immunology, 1989
- Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody.The Journal of Experimental Medicine, 1988
- Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin 1Diabetes, 1988
- HLA class II induction in human islet cells by interferon-γ plus tumour necrosis factor or lymphotoxinNature, 1987